Is There a Correlation Between Behçet Disease and Lower Urinary Tract Symptoms?

Overview

Journal Int Neurourol J

Date 2020 Jul 4

PMID 32615677

Citations 7

Authors

Aykut Baser

Ali Ersin Zumrutbas

Yusuf Ozlulerden

Okan Alkis

Aynure Oztekin

Sinan Celen

Zafer Aybek

Affiliations

Soon will be listed here.

Abstract

Purpose: In this study, we aimed to determine the prevalence of lower urinary tract symptoms (LUTS) in patients with Behçet disease (BD) and to investigate the relationship between the severity of BD and LUTS.

Methods: Fifty-five patients with BD were included in this study from January to December 2018. All patients received a detailed urological evaluation. Additionally, BD activity was investigated using the Behçet Disease Current Activation Form. The International Prostate Symptom Score (IPSS), International Consultation on Incontinence Questionnaire Short Form, 8-item overactive bladder questionnaire forms, uroflowmetry, and postvoid residual urine volume were evaluated.

Results: The mean age of the patients was 42.6 years. The mean activity score of BD was 4.6±3.2 and the mean IPSS score was 7.3±7.3. Sex had no significant effect on the BD activity score. The BD activity score was significantly correlated with the IPSS score, frequency of daytime urination, nocturia, and urgency. It was also correlated with the presence and the severity of urinary incontinence and the effect of urinary incontinence on daily life. Peak flow rate, voided volume, and the postvoid residual urine volume were not correlated with the BD activity score.

Conclusion: LUTS were highly prevalent in patients with BD, and the severity and current activity of BD were correlated with frequency, nocturia, urgency, and urinary incontinence. Therefore, a urological evaluation of patients with BD in whom the activity and severity of the disease is elevated should be carried out comprehensively and patients should be managed accordingly.

Citing Articles

The Current State of Artificial Intelligence Application in Urology.

Kim E, Eun S, Youn S Int Neurourol J. 2024; 27(4):227-233.

PMID: 38171322 PMC: 10762373. DOI: 10.5213/inj.2346336.168.

Development and Evaluation of Urolithiasis Detection Technology Based on a Multimethod Algorithm.

Park J, Eun S, Na Y Int Neurourol J. 2023; 27(1):70-76.

PMID: 37015727 PMC: 10073001. DOI: 10.5213/inj.2346070.035.

New Trends in Innovative Technologies Applying Artificial Intelligence to Urinary Diseases.

Oh J, Lee J, Eun S, Park J Int Neurourol J. 2023; 26(4):268-274.

PMID: 36599335 PMC: 9816452. DOI: 10.5213/inj.2244280.140.

A Study on the Optimal Artificial Intelligence Model for Determination of Urolithiasis.

Eun S, Yun M, Whangbo T, Kim K Int Neurourol J. 2022; 26(3):210-218.

PMID: 36203253 PMC: 9537435. DOI: 10.5213/inj.2244202.101.

Lower Urinary Tract Symptoms With a View Beyond the Bladder and Prostate.

Kim S Int Neurourol J. 2022; 26(2):85-86.

PMID: 35793985 PMC: 9260323. DOI: 10.5213/inj.2222edi02.

References

Akkoc N . Update on the epidemiology, risk factors and disease outcomes of Behçet's disease. Best Pract Res Clin Rheumatol. 2018; 32(2):261-270. DOI: 10.1016/j.berh.2018.08.010. View

Davatchi F . Behçet's disease. Int J Rheum Dis. 2019; 21(12):2057-2058. DOI: 10.1111/1756-185X.13465. View

Kirkali Z, Yigitbasi O, Sasmaz R . Urological aspects of Behçet's disease. Br J Urol. 1991; 67(6):638-9. DOI: 10.1111/j.1464-410x.1991.tb15230.x. View

Bang D, Yoon K, Chung H, Choi E, Lee E, Lee S . Epidemiological and clinical features of Behçet's disease in Korea. Yonsei Med J. 1998; 38(6):428-36. DOI: 10.3349/ymj.1997.38.6.428. View

Cetinel B, Akpinar H, Tufek I, Uygun N, Solok V, Yazici H . Bladder involvement in Behçet's syndrome. J Urol. 1999; 161(1):52-6. View

Davatchi F, Shahram F, Chams-Davatchi C, Shams H, Nadji A, Akhlaghi M . Behcet's disease: from East to West. Clin Rheumatol. 2010; 29(8):823-33. DOI: 10.1007/s10067-010-1430-6. View

Zouboulis C . Epidemiology of Adamantiades-Behçet's disease. Ann Med Interne (Paris). 2000; 150(6):488-98. View

Monastero R, Camarda C, Pipia C, Lopez G, Camarda L, Baiamonte V . Cognitive impairment in Behçet's disease patients without overt neurological involvement. J Neurol Sci. 2004; 220(1-2):99-104. DOI: 10.1016/j.jns.2004.02.021. View

Erdogru T, Kocak T, Serdaroglu P, Kadioglu A, Tellaloglu S . Evaluation and therapeutic approaches of voiding and erectile dysfunction in neurological Behçet's syndrome. J Urol. 1999; 162(1):147-53. DOI: 10.1097/00005392-199907000-00036. View

10.

Sarica K, Suzer O, Gurler A, Baltaci S, Ozdiler E, Dincel C . Urological evaluation of Behçet patients and the effect of colchicine on fertility. Eur Urol. 1995; 27(1):39-42. DOI: 10.1159/000475121. View

11.

Davatchi F . Behcet's disease. Int J Rheum Dis. 2014; 17(4):355-7. DOI: 10.1111/1756-185X.12378. View

12.

Karandreas N, Tsivgoulis G, Zambelis T, Kokotis P, Rapidi A, Petropoulou K . Urinary frequency in a case of Neuro-Behcet disease involving the brainstem - clinical, electrophysiological and urodynamic features. Clin Neurol Neurosurg. 2007; 109(9):806-10. DOI: 10.1016/j.clineuro.2007.07.003. View

13.

Vesely S, Knutson T, Damber J, Dicuio M, Dahlstrand C . Relationship between age, prostate volume, prostate-specific antigen, symptom score and uroflowmetry in men with lower urinary tract symptoms. Scand J Urol Nephrol. 2003; 37(4):322-8. DOI: 10.1080/00365590310014760. View

14.

Suzuki Kurokawa M, Suzuki N . Behcet's disease. Clin Exp Med. 2004; 4(1):10-20. DOI: 10.1007/s10238-004-0033-4. View

15.

Cetinel B, Obek C, Solok V, Yaycioglu O, Yazici H . Urologic screening for men with Behçet's syndrome. Urology. 1998; 52(5):863-5. DOI: 10.1016/s0090-4295(98)00341-0. View

16.

Krause I, Rosen Y, Kaplan I, Milo G, Guedj D, Molad Y . Recurrent aphthous stomatitis in Behçet's disease: clinical features and correlation with systemic disease expression and severity. J Oral Pathol Med. 1999; 28(5):193-6. DOI: 10.1111/j.1600-0714.1999.tb02023.x. View

17.

Bodur H, Borman P, Ozdemir Y, Atan C, Kural G . Quality of life and life satisfaction in patients with Behçet's disease: relationship with disease activity. Clin Rheumatol. 2005; 25(3):329-33. DOI: 10.1007/s10067-005-0046-8. View

18.

Mahr A, Maldini C . [Epidemiology of Behçet's disease]. Rev Med Interne. 2014; 35(2):81-9. DOI: 10.1016/j.revmed.2013.12.005. View

19.

Alizadeh F, Khorrami M, Izadpanahi M, Nouri-Mahdavi K, Sichani M . Bladder involvement in Behcet's disease. Urol J. 2012; 9(1):347-50. View

20.

Bang D . Clinical spectrum of Behçet's disease. J Dermatol. 2002; 28(11):610-3. DOI: 10.1111/j.1346-8138.2001.tb00044.x. View